Gerald J. Harris, MD, FACS

Publications

• Subperiosteal Abscess of the Orbit: Long-term Trends in Bacteriology and Clinical Outcomes and Current Management Recommendations.

  (Boal NS, Ataei Y, Hong SH, Wells TS, Griepentrog GJ, Esmaili N, Chisholm SAM, Harris GJ.) Ophthalmic Plast Reconstr Surg. 2024 Nov 26 PMID: 39588845 11/26/2024

• Orbital MALT lymphoma with amyloid deposition.

  (Bruce CN, Kroft SH, Harris GJ.) Orbit. 2024 Aug;43(4):526-530 PMID: 37125961 SCOPUS ID: 2-s2.0-85158855788 05/01/2023

• Inflammation and Fibrosis in Orbital Inflammatory Disease: A Histopathologic Analysis.

  (Verma R, Chen AJ, Choi D, Wilson DJ, Grossniklaus HE, Dailey RA, Ng JD, Steele EA, Planck SR, Czyz CN, Korn BS, Kikkawa DO, Foster JA, Kazim M, Harris GJ, Edward DP, Al Maktabi A, Rosenbaum JT.) Ophthalmic Plast Reconstr Surg. 2023 Nov-Dec 01;39(6):588-593 PMID: 37279012 PMCID: PMC10698206 SCOPUS ID: 2-s2.0-85176496554 06/06/2023

• Necrobiotic Xanthogranuloma With Associated Monoclonal Gammopathy Presenting as an Eyelid Nodule.

  (Punyamurthy NT, Tjahjono LA, Harris GJ, Wanat KA.) Ophthalmic Plast Reconstr Surg. 2023 Sep-Oct 01;39(5):e148-e150 PMID: 37279015 SCOPUS ID: 2-s2.0-85170294839 06/06/2023

• Pediatric Orbital Cellulitis/Abscess: Microbiology and Pattern of Antibiotic Prescribing.

  (Burek AG, Tregoning G, Pan A, Liegl M, Harris GJ, Havens PL.) WMJ. 2023 Mar;122(1):52-55 PMID: 36940123 SCOPUS ID: 2-s2.0-85150751891 03/21/2023

• Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.

  (Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ.) Ophthalmology. 2022 Apr;129(4):438-449 PMID: 34688699 SCOPUS ID: 2-s2.0-85120353489 10/25/2021

• Management of periocular cutaneous squamous cell carcinoma with perineural invasion: a case series and literature review.

  (Clark TJE, Harris GJ.) Orbit. 2022 Feb;41(1):34-43 PMID: 33663321 SCOPUS ID: 2-s2.0-85123969060 03/06/2021

• Biologics for thyroid eye disease

  (Stan MN, Garrity JAL, Carranza BG, Prabin T, Bradley EA, Bahn RS, Salvi M, Vannucchi G, Currò N, Campi I, Covelli D, Dazzi D, Simonetta S, Guastella C, Pignataro L, Avignone S, Beck-Peccoz P, Perez-Moreiras JV, Gomez-Reino JJ, Maneiro JR, Perez-Pampin E, Lopez AR, Alvarez FMR, Laguarta JMC, del Estad Cabello A, Sorroche MGG, España E, Sales-Sanz M, Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, Harris GJ, Antonelli A, Salvi M, Goldberg RA, Gigantelli JW, Couch SM, Shriver EM, Hayek BR, Hink EM, Woodward RM, Gabriel K, Magni G, Douglas RS.) Foundational Papers in Oculoplastics. 31 January 2022:481-498 SCOPUS ID: 2-s2.0-85156168997 01/31/2022

• Nonspecific orbital inflammatory disease

  (Blodi FC, Gass JD, Rootman J, McCarthy M, White V, Harris G, Kennerdell J, Rosenbaum JT, Choi D, Wilson DJ, Grossniklaus HE, Sibley CH, Harrington CA, Planck SR.) Foundational Papers in Oculoplastics. 31 January 2022:257-265 SCOPUS ID: 2-s2.0-85156134049 01/31/2022

• Bacterial infectious disease

  (Weiss A, Friendly D, Eglin K, Chang M, Gold B, Harris G.) Foundational Papers in Oculoplastics. 31 January 2022:237-243 SCOPUS ID: 2-s2.0-85156102200 01/31/2022

• Evaluation and Medical Management of the Pediatric Patient With Orbital Cellulitis/Abscess: A Systematic Review.

  (Burek AG, Melamed S, Liljestrom T, Qi J, Kelly TG, Suelzer E, Mitchell M, Harris GJ, Havens PL.) J Hosp Med. 2021 Nov;16(11):680-687 PMID: 34730499 SCOPUS ID: 2-s2.0-85121956444 11/04/2021

• Case Report: Idiopathic Sclerosing Orbital Inflammation.

  (Bachman Groth JA, Harris GJ.) Optom Vis Sci. 2021 Apr 01;98(4):409-417 PMID: 33852556 SCOPUS ID: 2-s2.0-85104462311 04/15/2021